Table 3.
Structures of the Fructus Ligustri Lucidi constituents identified in FTZ preparation and serum samples from FTZ-treated rats
| Type | Substituent group | Name of constituent | MW | Observed |
|---|---|---|---|---|
|
10-Hydroxyoleoside dimethyl ester | 434 | In serum and in preparation | |
|
|
Salidroside | 300 | In serum and in preparation | |
|
Oleuropeine aglycone | 378 | In preparation only | |
|
|
Oleuropeine | 540 | In preparation only | |
|
|
(+)-Pinoresinol-O-β-d-glucopyranoside | 520 | In preparation only | |
|
|
Coniferin | 342 | In preparation only | |
|
R1=OH, R2=OH, R3=R4=CH3, R5=R6=H | Masilinic acid | 472 | In serum and in preparation |
| R1=CH3COO, R2=H, R3=CH3, | ||||
| R4=H, R5=CH3, R6=OH | Pomolic acid acetate | 514 | In serum and in preparation | |
| R1=OH, R2=H, R3=R4=CH3, R5=R6=H | Oleanolic acid | 456 | In serum and in preparation | |
|
R=OH | Specnuezhenide | 686 | In preparation only |
|
|
Oleonuezhenide | 1072 | In preparation only |
In serum and in preparation: the constituent was observed both in FTZ-treated serum and FTZ preparation, in preparation only: the constituent was only observed in FTZ preparation, in serum only: the constituent was only observed in FTZ-treated serum
MW molecular weight